Phoxalone, a novel macrolide from Sorangium cellulosum: structure identification and its anti-tumor bioactivity in vitro

Biotechnol Lett. 2008 Feb;30(2):349-56. doi: 10.1007/s10529-007-9550-z. Epub 2007 Nov 8.

Abstract

A novel macrolide, isolated from the myxobacteria Sorangium cellulosum WXNXJ-C, was identified as 1,7,12,13-tetrahydroxy-14-methoxy-8,10-dimethyl-6-phenyl-5,15-dioxa-bicyclo[9.3.1]pentadecan-4-one, "Phoxalone". It had minimum IC(50) values of 0.24, 6.9, 10.3, 0.98 and 4 microg/ml, respectively, against tumour cell lines: B16, Bel7402, H446, MCF-7, and SGC7901. In addition, it had less cytotoxicity to normal human liver L02 cell lines (286 microg/ml, 24 h). A cytotoxic bioactivity study on H446 cell line in vitro suggested that Phoxalone arrested the mitosis in the G2/M phase.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Gas Chromatography-Mass Spectrometry
  • Hepatocytes / drug effects
  • Humans
  • Macrolides / chemistry*
  • Macrolides / isolation & purification
  • Macrolides / therapeutic use
  • Mice
  • Molecular Structure
  • Myxococcales / chemistry*
  • Myxococcales / genetics
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Macrolides
  • phoxalone